In article <qlc430lafacpd4ifcsp85rbdcoee0pmvoj at 4ax.com>, Doktor DynaSoar
<targeting at OMCL.mil> writes
>On Mon, 16 Feb 2004 07:29:28 GMT, "k p Collins"
><kpaulc@[----------]earthlink.net> wrote:
>>} I'm 'curious' - are folks waiting for me to
>} respond?
>>Nobody is waiting for anything.
>>} Everything I have to say about Neuropharmacology
>} has been in AoK, Ap9 all along ["functional multiplexing"]
>>If among that you have the specific answers regarding the affinities
>of the specified drugs to the monoaminergic transporters, then feel
>free. If not, then it has nothing to do with the question.
>
I once worked with DSP-4 (N-2-chloroethyl-N-ethyl-2-bromobenzylamine as
an alternative to 6-OHDA) whilst looking at forebrain NE' (and other
monomaines') role in various aspects of learning. It looks like the term
"transporter" is being used as a synonym for (presynaptic) "reuptake
receptor". Is that the case? I used to use DMI, 5-7 DHT, but not MDMA
in control groups. I thought these ligands were somewhat dirty and bound
to lots of receptors - is this what you're interested in, ie their
relative affinities - sorry if this has all been said earlier).
This is really a trivial question as I expect matters have moved on
considerably since my day (although I do try to keep up with some of
it).
--
David Longley